Offerings | Sep. 17, 2024 USD ($) shares |
Offering: 1 | |
Offering: | |
Fee Previously Paid | false |
Rule 457(r) | true |
Security Type | Debt |
Security Class Title | 3.800% Notes due 2029 |
Amount Registered | shares | 1,000,000,000 |
Maximum Aggregate Offering Price | $ 997,570,000 |
Fee Rate | 0.01476% |
Amount of Registration Fee | $ 147,241.33 |
Offering Note | Determined in accordance with Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"). |
Offering: 2 | |
Offering: | |
Fee Previously Paid | false |
Other Rule | true |
Security Type | Debt |
Security Class Title | Guarantees of 3.800% Notes due 2029 |
Fee Rate | 0.01476% |
Amount of Registration Fee | $ 0 |
Offering Note | Novartis AG has provided a guarantee with respect to the 3.800% Notes due 2029 issued by Novartis Capital Corporation. Pursuant to Rule 457(n) under the Securities Act, no additional registration fee is due with respect to the guarantees. |
Offering: 3 | |
Offering: | |
Fee Previously Paid | false |
Rule 457(r) | true |
Security Type | Debt |
Security Class Title | 4.000% Notes due 2031 |
Amount Registered | shares | 850,000,000 |
Maximum Aggregate Offering Price | $ 846,302,500 |
Fee Rate | 0.01476% |
Amount of Registration Fee | $ 124,914.25 |
Offering Note | Determined in accordance with Rule 457(r) under the Securities Act. |
Offering: 4 | |
Offering: | |
Fee Previously Paid | false |
Other Rule | true |
Security Type | Debt |
Security Class Title | Guarantees of 4.000% Notes due 2031 |
Fee Rate | 0.01476% |
Amount of Registration Fee | $ 0 |
Offering Note | Novartis AG has provided a guarantee with respect to the 4.000% Notes due 2031 issued by Novartis Capital Corporation. Pursuant to Rule 457(n) under the Securities Act, no additional registration fee is due with respect to the guarantees. |
Offering: 5 | |
Offering: | |
Fee Previously Paid | false |
Rule 457(r) | true |
Security Type | Debt |
Security Class Title | 4.200% Notes due 2034 |
Amount Registered | shares | 1,100,000,000 |
Maximum Aggregate Offering Price | $ 1,092,102,000 |
Fee Rate | 0.01476% |
Amount of Registration Fee | $ 161,194.26 |
Offering Note | Determined in accordance with Rule 457(r) under the Securities Act. |
Offering: 6 | |
Offering: | |
Fee Previously Paid | false |
Other Rule | true |
Security Type | Debt |
Security Class Title | Guarantees of 4.200% Notes due 2034 |
Fee Rate | 0.01476% |
Amount of Registration Fee | $ 0 |
Offering Note | Novartis AG has provided a guarantee with respect to the 4.200% Notes due 2034 issued by Novartis Capital Corporation. Pursuant to Rule 457(n) under the Securities Act, no additional registration fee is due with respect to the guarantees. |
Offering: 7 | |
Offering: | |
Fee Previously Paid | false |
Rule 457(r) | true |
Security Type | Debt |
Security Class Title | 4.700% Notes due 2054 |
Amount Registered | shares | 750,000,000 |
Maximum Aggregate Offering Price | $ 749,520,000 |
Fee Rate | 0.01476% |
Amount of Registration Fee | $ 110,629.15 |
Offering Note | Determined in accordance with Rule 457(r) under the Securities Act. |
Offering: 8 | |
Offering: | |
Fee Previously Paid | false |
Other Rule | true |
Security Type | Debt |
Security Class Title | Guarantees of 4.700% Notes due 2054 |
Fee Rate | 0.01476% |
Amount of Registration Fee | $ 0 |
Offering Note | Novartis AG has provided a guarantee with respect to the 4.700% Notes due 2054 issued by Novartis Capital Corporation. Pursuant to Rule 457(n) under the Securities Act, no additional registration fee is due with respect to the guarantees. |